Medigene

Medigene Net Margin

Delisted·Jul 2, 2026

The Net Profit Margin of Medigene (MDG1.DE) as of Oct 19, 2026 is -268.10 %. In the previous year, Net Profit Margin was -26.66 % — a change of 905.67% (lower).

Net Margin

-268.10 %

YoY

905.67%

Last updated:

Net Profit Margin of Medigene is 2023 -268.10 % . Net Profit Margin of Medigene was 2022 -26.66 % . It decreases by 905.67% lower compared to the previous year.

For Medigene, the net margin of -268.1% is down versus -187.8% a few years ago.

The Medigene Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2016
-97.36 EUR
Jan 1, 2017
-119.32 EUR
Jan 1, 2018
-219.87 EUR
Jan 1, 2019
-187.75 EUR
Jan 1, 2020
-330.04 EUR
Jan 1, 2021
-95.41 EUR
Jan 1, 2022
-26.66 EUR
Jan 1, 2023
-268.10 EUR
The Medigene Net Margin history
YEARNet MarginYoY
-268.10 %+905.67%
-26.66 %-72.06%
-95.41 %-71.09%
-330.04 %+75.78%
-187.75 %-14.61%
-219.87 %+84.27%
-119.32 %+22.55%
-97.36 %-49.01%
-190.94 %+357.16%
-41.77 %+2,983.89%
-1.35 %-13.68%
-1.57 %-216.30%
1.35 %-117.30%
-7.80 %+1,301.00%
-0.56 %-28.42%
-0.78 %-37.87%
-1.25 %+466.96%
-0.22 %-64.18%
-0.62 %-36.44%
-0.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medigene Stock analysis

What does Medigene do? Medigene AG, based in Planegg, Germany, is a biotechnology company specializing in developing innovative cancer treatment platforms. The company focuses on personalized T cell-based immunotherapies, including TCR-modified T cells for adoptive therapy, dendritic cell vaccines for low tumor burdens, and T-cell-specific monoclonal antibodies. It operates offices in Martinsried, Germany, and in Washington DC and San Diego, USA, with 136 employees. Medigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medigene stock

Net Profit Margin of Medigene is -268.10 % in 2023.

Net Profit Margin of Medigene changed from -26.66 % to -268.10 %, representing a 905.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Medigene since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Medigene with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Medigene

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Medigene